These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26472728)

  • 1. Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo.
    Cremer C; Braun H; Mladenov R; Schenke L; Cong X; Jost E; Brümmendorf TH; Fischer R; Carloni P; Barth S; Nachreiner T
    Cancer Immunol Immunother; 2015 Dec; 64(12):1575-86. PubMed ID: 26472728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations.
    Cong X; Cremer C; Nachreiner T; Barth S; Carloni P
    Protein Sci; 2016 Aug; 25(8):1451-60. PubMed ID: 27110669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenin mutants as novel effector molecules for the generation of fusion proteins with increased cytotoxic potential.
    Cremer C; Vierbuchen T; Hein L; Fischer R; Barth S; Nachreiner T
    J Immunother; 2015 Apr; 38(3):85-95. PubMed ID: 25710248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival.
    Pizzo E; Sarcinelli C; Sheng J; Fusco S; Formiggini F; Netti P; Yu W; D'Alessio G; Hu GF
    J Cell Sci; 2013 Sep; 126(Pt 18):4308-19. PubMed ID: 23843625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor.
    Thomas SP; Hoang TT; Ressler VT; Raines RT
    RNA; 2018 Aug; 24(8):1018-1027. PubMed ID: 29748193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
    Schiffer S; Letzian S; Jost E; Mladenov R; Hristodorov D; Huhn M; Fischer R; Barth S; Thepen T
    Cancer Lett; 2013 Dec; 341(2):178-85. PubMed ID: 23973499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.
    Bochicchio A; Jordaan S; Losasso V; Chetty S; Perera RC; Ippoliti E; Barth S; Carloni P
    Biomedicines; 2017 Feb; 5(1):. PubMed ID: 28536352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease.
    Sarangdhar MA; Allam R
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
    Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
    Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
    Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
    Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
    Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells.
    Stöcker M; Tur MK; Sasse S; Krüssmann A; Barth S; Engert A
    Protein Expr Purif; 2003 Apr; 28(2):211-9. PubMed ID: 12699683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Angiogenin and Ribonuclease 4 variants associated with amyotrophic lateral sclerosis exhibit loss-of-function: a comprehensive in silico study.
    Padhi AK; Narain P; Gomes J
    Metab Brain Dis; 2019 Dec; 34(6):1661-1677. PubMed ID: 31368019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of the Ribonuclease Inhibitor Gene Leaves Human Cells Vulnerable to Secretory Ribonucleases.
    Thomas SP; Kim E; Kim JS; Raines RT
    Biochemistry; 2016 Nov; 55(46):6359-6362. PubMed ID: 27806571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis.
    Padhi AK; Kumar H; Vasaikar SV; Jayaram B; Gomes J
    PLoS One; 2012; 7(2):e32479. PubMed ID: 22384259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.
    Saxena SK; Rybak SM; Davey RT; Youle RJ; Ackerman EJ
    J Biol Chem; 1992 Oct; 267(30):21982-6. PubMed ID: 1400510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitor-resistant cytotoxic variants.
    Gaur D; Swaminathan S; Batra JK
    J Biol Chem; 2001 Jul; 276(27):24978-84. PubMed ID: 11342552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and functional characterization of Angiogenin mutations, and correlation with amyotrophic lateral sclerosis.
    Padhi AK; Banerjee K; Gomes J; Banerjee M
    PLoS One; 2014; 9(11):e111963. PubMed ID: 25372031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
    Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
    Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.